Literature DB >> 9605900

Comparison of molecular changes in lung cancers in HIV-positive and HIV-indeterminate subjects.

I I Wistuba1, C Behrens, S Milchgrub, A K Virmani, J Jagirdar, B Thomas, H L Ioachim, L A Litzky, E M Brambilla, J D Minna, A F Gazdar.   

Abstract

CONTEXT: Human immunodeficiency virus (HIV) infection has been associated with an increasing incidence of malignancy, and HIV-infected persons have an increased incidence of primary lung carcinoma compared with the general population.
OBJECTIVE: To investigate the molecular changes present in HIV-associated lung tumors and compare them with those present in lung carcinomas arising in HIV-indeterminate subjects ("sporadic tumors").
DESIGN: Convenience sample.
SUBJECTS: Archival tissues from 11 HIV-positive persons and from 35 persons of indeterminate HIV status.
SETTING: University-based medical centers and affiliated hospitals. MAIN OUTCOME MEASURES: Analysis of frequency of loss of heterozygosity (LOH) and microsatellite alteration (MA) using polymerase chain reaction and 16 polymorphic microsatellite markers at 8 chromosomal regions frequently deleted in lung cancer. Presence of HIV and human papillomavirus (HPV) sequences.
RESULTS: The overall frequency of LOH at all chromosomal regions tested and the frequencies at most of the individual regions were similar in the 2 groups. Frequency of MA present in the HIV-associated tumors (0.18) was 6-fold higher than in sporadic tumors (0.03) (P<.001). At least 1 MA was present in 10 (91%) of 11 HIV-associated tumors vs 17 (48%) of 35 sporadic tumors (P=.02). Molecular changes were independent of tumor stage and gender. HIV and HPV sequences were not detected in the HIV-associated lung carcinomas.
CONCLUSIONS: Microsatellite alterations, which reflect widespread genomic instability, occur at greatly increased frequency in HIV-associated lung carcinomas. Although the mechanism underlying the development of increased MAs is unknown, it may play a crucial role in the development of many HIV-associated tumors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9605900     DOI: 10.1001/jama.279.19.1554

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  34 in total

Review 1.  HPV infections and lung cancer.

Authors:  K J Syrjänen
Journal:  J Clin Pathol       Date:  2002-12       Impact factor: 3.411

Review 2.  The rising challenge of non-AIDS-defining cancers in HIV-infected patients.

Authors:  John F Deeken; Angelique Tjen-A-Looi; Michelle A Rudek; Catherine Okuliar; Mary Young; Richard F Little; Bruce J Dezube
Journal:  Clin Infect Dis       Date:  2012-07-09       Impact factor: 9.079

3.  High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele loss.

Authors:  A Maitra; I I Wistuba; C Washington; A K Virmani; R Ashfaq; S Milchgrub; A F Gazdar; J D Minna
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

Review 4.  The role of viral and bacterial pathogens in gastrointestinal cancer.

Authors:  Michael Selgrad; Peter Malfertheiner; Lucia Fini; Ajay Goel; C Richard Boland; Luigi Ricciardiello
Journal:  J Cell Physiol       Date:  2008-08       Impact factor: 6.384

5.  HIV-1 Nef promotes cell proliferation and microRNA dysregulation in lung cells.

Authors:  Maryline Santerre; Wissam Chatila; Ying Wang; Ruma Mukerjee; Bassel E Sawaya
Journal:  Cell Cycle       Date:  2019-01-06       Impact factor: 4.534

Review 6.  Lung cancer in HIV Infection.

Authors:  Deepthi Mani; Missak Haigentz; David M Aboulafia
Journal:  Clin Lung Cancer       Date:  2011-07-29       Impact factor: 4.785

7.  Single-institutional experience of clinicopathological analysis and treatment for lung cancer patients with human immunodeficiency virus infection.

Authors:  Satoshi Takahashi; Yusuke Okuma; Kageaki Watanabe; Yukio Hosomi; Akifumi Imamura; Tatsuru Okamura; Akihiko Gemma
Journal:  Mol Clin Oncol       Date:  2017-04-06

Review 8.  Epidemic of lung cancer in patients with HIV infection.

Authors:  Tiffany A Winstone; S F Paul Man; Mark Hull; Julio S Montaner; Don D Sin
Journal:  Chest       Date:  2013-02-01       Impact factor: 9.410

Review 9.  Lung cancer in HIV infected patients: facts, questions and challenges.

Authors:  J Cadranel; D Garfield; A Lavolé; M Wislez; B Milleron; C Mayaud
Journal:  Thorax       Date:  2006-11       Impact factor: 9.139

10.  Clinicopathologic Features of Colorectal Carcinoma in HIV-Positive Patients.

Authors:  Carlie Sigel; Marcela S Cavalcanti; Tanisha Daniel; Efsevia Vakiani; Jinru Shia; Keith Sigel
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-05-13       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.